CAP2 and schizophrenia: Taken together, while global spatial stability alterations in several states characterize the disease process, the specific and robust destabilization of CAP2 in the SCH_Neg group points toward a key mechanism underlying symptom heterogeneity in schizophrenia (Pico‐Perez et al. 2022; Vanes et al. 2019; Voineskos et al. 2024), where preserved sensorimotor integration might serve as a protective factor against negative symptoms.